Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer.

Pizzo, B A; Pérez, W; McClean, N; Kris, M G; Miller, V A; Krug, L M; Ng, K. K.; Kraut, M J; Kalemkerian, G P; Heelan, R T

Record: found
Abstract: not found
Article: not found

Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer.

Author(s): B Pizzo, W Pérez, N McClean, M Kris, V A Miller, L M Krug, K. Ng, M Kraut, G Kalemkerian, R T Heelan

Publication date: 2000-02-01

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Read this article at

ScienceOpenPubMed

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

PubMed ID:: 10761761

Data availability:

Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer.

Read this article at

Related collections

Inflamed lung in vitro co-culture models

Author and article information

Journal

Comments

Comment on this article